메뉴 건너뛰기




Volumn 164, Issue 584, 1999, Pages 79-84

Concept of and preliminary trial protocol for adjuvant treatment of mediastinitis with immunoglobulins after cardiac surgery (ATMI): Response to comments and criticism

Author keywords

ATMI; Cardiac surgery; Critical care medicine; Immunoglobulin therapy; Mediastinitis

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; ANTIINFECTIVE AGENT; CYTOKINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; PENTAGLOBULIN;

EID: 0033287090     PISSN: 1102416X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (1)

References (47)
  • 1
    • 0009529293 scopus 로고    scopus 로고
    • Downregulation of cytokine synthesis during cardiopulmonary bypass
    • 1a. Börgermann J, Friedrich I, Feldt T, et al. Down-regulation of cytokine synthesis during cardiopulmonary bypass. Shock 1997; 8 (Suppl): 114.
    • (1997) Shock , vol.8 , Issue.SUPPL. , pp. 114
    • Börgermann, J.1    Friedrich, I.2    Feldt, T.3
  • 2
    • 0025805047 scopus 로고
    • Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune golbulin to neonates with clinical signs of early-onset sepsis
    • 1b. Christensen RD, Brown MS, Hall DC, Lassiter HA, Hill HR. Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune golbulin to neonates with clinical signs of early-onset sepsis. J Pediatr 1991; 118: 606-614.
    • (1991) J Pediatr , vol.118 , pp. 606-614
    • Christensen, R.D.1    Brown, M.S.2    Hall, D.C.3    Lassiter, H.A.4    Hill, H.R.5
  • 3
    • 0021247249 scopus 로고
    • Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa
    • 2. Collins MS, Roby RE. Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa. Am J Med 1984; 76: 168-174.
    • (1984) Am J Med , vol.76 , pp. 168-174
    • Collins, M.S.1    Roby, R.E.2
  • 4
    • 0016044643 scopus 로고
    • Therapeutic intervention scoring system: A method for quantitative comparison of patient care
    • 3. Cullen DJ, Civetta JM, Briggs BA, et al. Therapeutic intervention scoring system: a method for quantitative comparison of patient care. Crit Care Med 1974; 2: 57-60.
    • (1974) Crit Care Med , vol.2 , pp. 57-60
    • Cullen, D.J.1    Civetta, J.M.2    Briggs, B.A.3
  • 5
    • 0032586351 scopus 로고    scopus 로고
    • Outcome assessment - The pros and cons of TISS as the primary objective
    • 4. Dellinger RP. Outcome assessment - the pros and cons of TISS as the primary objective. Eur J Surg 1999; Suppl 584: 49-50.
    • (1999) Eur J Surg , Issue.SUPPL. 584 , pp. 49-50
    • Dellinger, R.P.1
  • 6
    • 0023241561 scopus 로고
    • Untersuchung sur Wirksamkeit von Immunglobulin M-angereicherten, intravenösen Immunglobulinen gegen bakterielle Infektionen und sur Neutralisation bakterieller Toxine
    • 5. Dichtelmüller H, Stephan W. Untersuchung sur Wirksamkeit von Immunglobulin M-angereicherten, intravenösen Immunglobulinen gegen bakterielle Infektionen und sur Neutralisation bakterieller Toxine. Arsneim Forsch Drug Res 1987; 11: 1273-1276.
    • (1987) Arsneim Forsch Drug Res , vol.11 , pp. 1273-1276
    • Dichtelmüller, H.1    Stephan, W.2
  • 7
    • 0024277322 scopus 로고
    • IgM-Antikörper gegen das Toxic-shock Syndrom Toxin-1 in Humanseren und Human-Immmunglobulinen
    • 6. Dickgiesser N, Düsgün F. IgM-Antikörper gegen das Toxic-shock Syndrom Toxin-1 in Humanseren und Human-Immmunglobulinen. Klin Wochenschr 1988; 66: 7-11.
    • (1988) Klin Wochenschr , vol.66 , pp. 7-11
    • Dickgiesser, N.1    Düsgün, F.2
  • 8
    • 0032586355 scopus 로고    scopus 로고
    • Considerations on the statistical design of the ATMI-study
    • 7. Eisebitt R, Lehmacher W, Lefering R. Considerations on the statistical design of the ATMI-study. Eur J Surg 1999; Suppl 584: 68-69.
    • (1999) Eur J Surg , Issue.SUPPL. 584 , pp. 68-69
    • Eisebitt, R.1    Lehmacher, W.2    Lefering, R.3
  • 9
    • 0029918478 scopus 로고    scopus 로고
    • Postoperative mediastinitis: Classification and management
    • 8. El Oakley RM, Wright JE. Postoperative mediastinitis: classification and management. Ann Thorac Surg 1996; 61: 1030-1036.
    • (1996) Ann Thorac Surg , vol.61 , pp. 1030-1036
    • El Oakley, R.M.1    Wright, J.E.2
  • 10
    • 0024550748 scopus 로고
    • Opsonic activity of a new intravenous immunoglobulin preparation: Pentaglobin® compared with Sandoglobulin
    • 9. Garbett ND, Munro CS, Cole PJ. Opsonic activity of a new intravenous immunoglobulin preparation: Pentaglobin® compared with Sandoglobulin. Clin Exp Immunol 1989; 76: 8-12.
    • (1989) Clin Exp Immunol , vol.76 , pp. 8-12
    • Garbett, N.D.1    Munro, C.S.2    Cole, P.J.3
  • 11
    • 0019426197 scopus 로고
    • Complement activation and neutropenia occurring during cardiopulmonary bypass
    • 10. Hammerschmidt D, Storncek D, Bowers T, et al. Complement activation and neutropenia occurring during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1981; 81: 370-377.
    • (1981) J Thorac Cardiovasc Surg , vol.81 , pp. 370-377
    • Hammerschmidt, D.1    Storncek, D.2    Bowers, T.3
  • 12
    • 0022745346 scopus 로고
    • Protective and opsonic activities of a native pH 4.25 intravenous immunoglobulin G preparation against common bacterial pathogens
    • 11. Hill HR, Bathras JM. Protective and opsonic activities of a native pH 4.25 intravenous immunoglobulin G preparation against common bacterial pathogens. Rev Infect Dis 1986; 8(Suppl): S396-S400.
    • (1986) Rev Infect Dis , vol.8 , Issue.SUPPL.
    • Hill, H.R.1    Bathras, J.M.2
  • 14
    • 0020959670 scopus 로고
    • Therapeutic intervention scoring system: Update 1983
    • 13. Keene AR, Cullen DJ. Therapeutic Intervention Scoring System: update 1983. Crit Care Med 1983; 11: 1-3.
    • (1983) Crit Care Med , vol.11 , pp. 1-3
    • Keene, A.R.1    Cullen, D.J.2
  • 15
    • 0009524355 scopus 로고
    • Pathomechanisms of defective hemostasis during and after extracorporeal circulation: Contact activation
    • Friedel N, Hetser R, Royston D, eds. Darmstadt: Steinkopff
    • 14. Kluft C. Pathomechanisms of defective hemostasis during and after extracorporeal circulation: contact activation. In: Friedel N, Hetser R, Royston D, eds: Bolld use in cardiac surgery. Darmstadt: Steinkopff, 1991: 10-15.
    • (1991) Bolld Use in Cardiac Surgery , pp. 10-15
    • Kluft, C.1
  • 16
    • 0032586350 scopus 로고    scopus 로고
    • Thoracic transposition of the greater omentum as an adjunct in the treatment of mediastinitis - Pros and cons within the context of a randomised trial
    • 15. Krabatsch T, Schmitt DV, Mohr FW, Hetzer R. Thoracic transposition of the greater omentum as an adjunct in the treatment of mediastinitis - pros and cons within the context of a randomised trial. Eur J Surg 1999; Suppl 584: 45-48.
    • (1999) Eur J Surg , Issue.SUPPL. 584 , pp. 45-48
    • Krabatsch, T.1    Schmitt, D.V.2    Mohr, F.W.3    Hetzer, R.4
  • 17
    • 0009498329 scopus 로고    scopus 로고
    • Reduced incidence of postoperative infection following intravenous application of an IgM and IgM-enriched immunoglobulin preparation in anergic patients undergoing cardiac surgery
    • in press
    • 16. Kress HG, Seidewig C, Schmidt H, Silber R. Reduced incidence of postoperative infection following intravenous application of an IgM and IgM-enriched immunoglobulin preparation in anergic patients undergoing cardiac surgery. Crit Care Med: in press,
    • Crit Care Med
    • Kress, H.G.1    Seidewig, C.2    Schmidt, H.3    Silber, R.4
  • 18
    • 0000550066 scopus 로고    scopus 로고
    • Objektivierung der Organ (dys-)funktion in der Intensivmedisin - Warum und wie?
    • 17. Lefering R, Neugebauer E. Objektivierung der Organ (dys-)funktion in der Intensivmedisin - Warum und wie? Intensivmed 1998; 35: 177-181.
    • (1998) Intensivmed , vol.35 , pp. 177-181
    • Lefering, R.1    Neugebauer, E.2
  • 19
    • 0031324251 scopus 로고    scopus 로고
    • Effektivkosten der Intensivtherapie: TISS und TISS-28 zur Evaluation einer Intensivstation
    • 18. Lefering R, Zart M, Neugebauer E. Effektivkosten der Intensivtherapie: TISS und TISS-28 zur Evaluation einer Intensivstation. Langenbecks Arch Chir (Suppl II) 1997; 1393.
    • (1997) Langenbecks Arch Chir , Issue.SUPPL. II , pp. 1393
    • Lefering, R.1    Zart, M.2    Neugebauer, E.3
  • 20
    • 0032586354 scopus 로고    scopus 로고
    • Biostatistical aspects of outcome evaluation using TISS-28
    • 19. Lefering R. Biostatistical aspects of outcome evaluation using TISS-28. Eur J Surg 1999; Suppl 584: 56-61.
    • (1999) Eur J Surg , Issue.SUPPL. 584
    • Lefering, R.1
  • 21
    • 0032586346 scopus 로고    scopus 로고
    • Efficacy and potential clinical applications of Pentaglobin®, an IgM-enriched immunoglobulin concentrate suitable for intravenous infusion
    • 20. Lissner R, Struff WG, Autenrieth IB, Woodcock BG, Karch H. Efficacy and potential clinical applications of Pentaglobin®, an IgM-enriched immunoglobulin concentrate suitable for intravenous infusion. Eur J Surg; Suppl 584: 17-25.
    • Eur J Surg , Issue.SUPPL. 584 , pp. 17-25
    • Lissner, R.1    Struff, W.G.2    Autenrieth, I.B.3    Woodcock, B.G.4    Karch, H.5
  • 22
    • 0025219806 scopus 로고
    • Sternal wound complications after isolated coronary artery bypass grafting: Early and late mortality, morbidity, and cost of care
    • 21. Loop FD, Lytle BW, Cosgrove DM, et al. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity, and cost of care. Ann Thorac Surg 1990; 49: 179-187.
    • (1990) Ann Thorac Surg , vol.49 , pp. 179-187
    • Loop, F.D.1    Lytle, B.W.2    Cosgrove, D.M.3
  • 24
    • 0024553333 scopus 로고
    • Opsonic activitiy in serum from septic infants treated with intravenous immunoglobulin
    • 23. Marödi L, Kalmár A, Ssabó I. Opsonic activitiy in serum from septic infants treated with intravenous immunoglobulin. Arch Dis Child 1989; 64: 530-534.
    • (1989) Arch Dis Child , vol.64 , pp. 530-534
    • Marödi, L.1    Kalmár, A.2    Ssabó, I.3
  • 25
    • 0032586353 scopus 로고    scopus 로고
    • Organ dysfunction as an outcome measure in clinical trials
    • 24. Marshall JC. Organ dysfunction as an outcome measure in clinical trials Eur J Surg 1999; Suppl 584: 62-67.
    • (1999) Eur J Surg , Issue.SUPPL. 584 , pp. 62-67
    • Marshall, J.C.1
  • 26
    • 0028208797 scopus 로고
    • Multicenter trials in sepsis and septic shock. Necessary prerequisites elaborated on the trial of supplemental immunoglobulin treatment of Pilz et al
    • 25. Neugebauer E. Multicenter trials in sepsis and septic shock. Necessary prerequisites elaborated on the trial of supplemental immunoglobulin treatment of Pilz et al. Theor Surg 1994; 9: 60-62.
    • (1994) Theor Surg , vol.9 , pp. 60-62
    • Neugebauer, E.1
  • 27
    • 0032586344 scopus 로고    scopus 로고
    • Development of a consensus-assisted protocol - A new approach to improve study design
    • 26. Neugebauer E. Development of a consensus-assisted protocol - a new approach to improve study design. Eur J Surg 1999; Suppl 584: 7-11.
    • (1999) Eur J Surg , Issue.SUPPL. 584 , pp. 7-11
    • Neugebauer, E.1
  • 28
    • 0001172828 scopus 로고    scopus 로고
    • Modulation of the humoral mediator network in the treatment of shock and sepsis
    • Okada K, Ogata H, eds. Amsterdam: Elsevier
    • 27. Neugebauer E, Schäfer U, Rixen D, Bouillon B. Modulation of the humoral mediator network in the treatment of shock and sepsis. In: Okada K, Ogata H, eds: Shock from molecular and cellular level to whole body. Amsterdam: Elsevier; 1996: 275-288.
    • (1996) Shock from Molecular and Cellular Level to Whole Body , pp. 275-288
    • Neugebauer, E.1    Schäfer, U.2    Rixen, D.3    Bouillon, B.4
  • 29
    • 84938030174 scopus 로고
    • Septic shock: Hemodynamics and pathogensesis
    • 28. Parker MM, Parrillo JE. Septic shock: hemodynamics and pathogensesis. JAMA 1983; 250: 3324-3327.
    • (1983) Jama , vol.250 , pp. 3324-3327
    • Parker, M.M.1    Parrillo, J.E.2
  • 30
    • 0027532444 scopus 로고
    • Supplemental immunoglobulin treatment in sepsis and septic shock - Comparison of mortality under treatment with polyvalent i.v. immunoglobulin versus placebo. Protocol of a multicenter, randomised, prospective, double-blind trial
    • 29. Pilz G, Fateh-Moghadam S, Viell B, et al. Supplemental immunoglobulin treatment in sepsis and septic shock -comparison of mortality under treatment with polyvalent i.v. immunoglobulin versus placebo. Protocol of a multicenter, randomised, prospective, double-blind trial. Theor Surg 1993; 8: 61-83.
    • (1993) Theor Surg , vol.8 , pp. 61-83
    • Pilz, G.1    Fateh-Moghadam, S.2    Viell, B.3
  • 31
    • 0032586352 scopus 로고    scopus 로고
    • Outcome assessment - TISS as a tool to evaluate cost-effectiveness of immunological treatment
    • 30. Reis Miranda D. Outcome assessment - TISS as a tool to evaluate cost-effectiveness of immunological treatment. Eur J Surg 1999; Suppl 584: 51-55.
    • (1999) Eur J Surg , Issue.SUPPL. 584 , pp. 51-55
    • Reis Miranda, D.1
  • 32
    • 0029898011 scopus 로고    scopus 로고
    • Simplified therapeutic intervention scoring system: The TISS-28 items - Results from a multicenter study
    • 31. Reis Miranda D, De Rijk A, Schaufli WB. Simplified therapeutic intervention scoring system: the TISS-28 items - results from a multicenter study. Crit Care Med 1996; 24: 64-73.
    • (1996) Crit Care Med , vol.24 , pp. 64-73
    • Reis Miranda, D.1    De Rijk, A.2    Schaufli, W.B.3
  • 33
    • 0009463491 scopus 로고    scopus 로고
    • Blocking of complement activation by intravenously applicable IgG, -M, and -A preparations: Analysis of the efficacy of C4b-and C3b-scavenging
    • Innsbruck, March 12-15
    • 32. Rieben R, Gerritsen AF, Nydegger UE, Daha MR. Blocking of complement activation by intravenously applicable IgG, -M, and -A preparations: analysis of the efficacy of C4b-and C3b-scavenging. 6th European Meeting on Complement in Human Disease, Innsbruck, March 12-15; 1997.
    • (1997) 6th European Meeting on Complement in Human Disease
    • Rieben, R.1    Gerritsen, A.F.2    Nydegger, U.E.3    Daha, M.R.4
  • 34
    • 0032586348 scopus 로고    scopus 로고
    • Comments on the study protocol: Adjuvant treatment of mediastinitis (ATMI) with immunoglobulins (Pentaglobin®) after cardiac surgery
    • 33. Robicsek F. Comments on the study protocol: Adjuvant treatment of mediastinitis (ATMI) with immunoglobulins (Pentaglobin®) after cardiac surgery. Eur J Surg 1999; Suppl 584: 39-42.
    • (1999) Eur J Surg , Issue.SUPPL. 584 , pp. 39-42
    • Robicsek, F.1
  • 35
    • 0027745701 scopus 로고
    • Effects of interleukin-2 treatment in patients with common variable immunodeficiency (CVID)
    • 34. Rump JA, Jahreis A, Schlesier M, et al. Effects of interleukin-2 treatment in patients with common variable immunodeficiency (CVID). Immunodeficiency 1993; 4: 37-42.
    • (1993) Immunodeficiency , vol.4 , pp. 37-42
    • Rump, J.A.1    Jahreis, A.2    Schlesier, M.3
  • 36
    • 0028897194 scopus 로고
    • Complement activation and release of tumor necrosis factor-alpha, interleukin-2, and soluble tumor necrosis factor and interleukin-2 receptors during and after cardiopulmonary bypass in children
    • 35. Saatvedt K, Lindberg H, Geiran OR, et al. Complement activation and release of tumor necrosis factor-alpha, interleukin-2, and soluble tumor necrosis factor and interleukin-2 receptors during and after cardiopulmonary bypass in children. Scan J Clin Lab Invest 1995; 55: 79-86.
    • (1995) Scan J Clin Lab Invest , vol.55 , pp. 79-86
    • Saatvedt, K.1    Lindberg, H.2    Geiran, O.R.3
  • 37
    • 0021131296 scopus 로고
    • Mediastinal infection after cardiac surgery
    • 36. Sarr MG, Gott VL, Townsend R. Mediastinal infection after cardiac surgery. Ann Thorac Surg 1984; 38: 415-424.
    • (1984) Ann Thorac Surg , vol.38 , pp. 415-424
    • Sarr, M.G.1    Gott, V.L.2    Townsend, R.3
  • 38
    • 0029922017 scopus 로고    scopus 로고
    • A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor concentrations and outcome of patients with severe sepsis
    • 37. Schade FU. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor concentrations and outcome of patients with severe sepsis. Crit Care Med 1996; 24: 381-384.
    • (1996) Crit Care Med , vol.24 , pp. 381-384
    • Schade, F.U.1
  • 39
    • 0032586358 scopus 로고    scopus 로고
    • Relation of the bi-allelic NcoI restriction fragment length polymorphism within the tumour necrosis factor b gene to the development of mediastinitis
    • 38. Schade FU, Stüber F, Börgermann J, Majetschak M. Relation of the bi-allelic NcoI restriction fragment length polymorphism within the tumour necrosis factor b gene to the development of mediastinitis. Eur J Surg 1999; Suppl 584: 73-78.
    • (1999) Eur J Surg , Issue.SUPPL. 584 , pp. 73-78
    • Schade, F.U.1    Stüber, F.2    Börgermann, J.3    Majetschak, M.4
  • 40
    • 0032586349 scopus 로고    scopus 로고
    • Microbiology and antibiotic treatment - Discussion forum on a study protocol on adjuvant treatment of mediastinitis with immunoglobulin (Pentaglobin®) after cardiac surgery (ATMI)
    • 39. Solomkin JS. Microbiology and antibiotic treatment -Discussion forum on a study protocol on adjuvant treatment of mediastinitis with immunoglobulin (Pentaglobin®) after cardiac surgery (ATMI). Eur J Surg 1999; Suppl 584: 43-44.
    • (1999) Eur J Surg , Issue.SUPPL. 584 , pp. 43-44
    • Solomkin, J.S.1
  • 41
    • 0031028218 scopus 로고    scopus 로고
    • Cytokine responses to cardiopulmonary bypass: Lessons learned from cardiac transplantation
    • 40. Song W, LeClere JL, Vincent JL. Cytokine responses to cardiopulmonary bypass: Lessons learned from cardiac transplantation. Ann Thorac Surg 1997; 63: 269-276.
    • (1997) Ann Thorac Surg , vol.63 , pp. 269-276
    • Song, W.1    LeClere, J.L.2    Vincent, J.L.3
  • 44
    • 0033291932 scopus 로고    scopus 로고
    • Immunological monitoring of the inflammatory process: Which variables? When to assess?
    • 43. Volk HD, Reinke P, Döcke WD. Immunological monitoring of the inflammatory process: Which variables? When to assess? Eur J Surg 1999; Suppl 584: 70-72.
    • (1999) Eur J Surg , Issue.SUPPL. 584 , pp. 70-72
    • Volk, H.D.1    Reinke, P.2    Döcke, W.D.3
  • 45
    • 0032586347 scopus 로고    scopus 로고
    • The overall concept: Immunoglobulins as adjuvants for mediastinitis - Does it make sense?
    • 44. Werdan K. The overall concept: immunoglobulins as adjuvants for mediastinitis - Does it make sense? Eur J Surg 1999; Suppl 584: 33-38.
    • (1999) Eur J Surg , Issue.SUPPL. 584 , pp. 33-38
    • Werdan, K.1
  • 46
    • 0029996366 scopus 로고    scopus 로고
    • Supplemental immunoglobulins in sepsis: A critical appraisal
    • 45. Werdan K, Pilz G. Supplemental immunoglobulins in sepsis: a critical appraisal. Clin Exp Immunol 1996; 104: 83-90.
    • (1996) Clin Exp Immunol , vol.104 , pp. 83-90
    • Werdan, K.1    Pilz, G.2
  • 47
    • 0029739445 scopus 로고    scopus 로고
    • Immunomodulatory effect of immunoglobulins
    • 46. Wolf HM, Eibl MM. Immunomodulatory effect of immunoglobulins. Clin Exp Rheumatol 1996; 14(Suppl 15): 517-525.
    • (1996) Clin Exp Rheumatol , vol.14 , Issue.SUPPL. 15 , pp. 517-525
    • Wolf, H.M.1    Eibl, M.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.